American Society of Addiciton Medicine

The Taskforce


The Taskforce


ASAM Clinical Guidance Task Force

COVID-19 was declared a world pandemic on March 11.  Patients with addiction are a vulnerable population with unique challenges in light of COVID-19.  Many patients with addiction have other co-occurring conditions and depending on the severity of their disease and access to economic and social support, such individuals may cycle in and out of emergency departments, addiction treatment centers, homeless shelters and other facilities.  These circumstances pose unique challenges regarding COVID-19 transmission and the severity of the illness if contracted by patients with SUD. At the very least proper attention to infectious disease issues will decrease the infection rate among this population and their families.

This Task Force is charged to develop guidance resources for clinicians to use as they sort out how to handle the impact of COVID-19 on their practice and in the treatment of patients with addiction.

As of: 4/17/20

Task Force Members

Yngvild Olsen, MD, MPH, DFASAM Chair

Kelly Clark, MD, MBA, DFAPA, DFASAM Vice Chair

Anika Alvanzo, MD, MS, FACP, DFASAM

Gregory X. Boehm, MD, DFASAM

Chris Bundy, MD, MPH, FASAM

Megan Buresh, MD

Chinazo O. Cunningham, MD, MS, FASAM

Itai Danovitch, MD, MBA, FAPA, DFASAM

Laura Fanucchi, MD, MPH, FASAM

Kevin Fiscella, MD, MPH. FASAM

David Goodman, MD

P. Bradley Hall, MD, DABAM, DFASAM

Scott L. Hambleton, MD, DFASAM

Brian Hurley, MD, MBA, DFASAM

Margaret A. Jarvis, MD, DFASAM

Hendree Jones, PhD

Sarah Kawasaki, MD, FASAM

Bobby P. Kearney, MD, FASAM

George KolodnerMD, DLFAPA, FASAM

Miriam Komaromy, MD, FACP, DFASAM

Ilse Levin, DO, MPH&TM, FACP

Marjorie Meyer, MD

Julio Meza, MD

Lewis Nelson, MD, FASAM

Cara A. Poland, MD, MEd, DFASAM

Alexis Polles, MD

Shawn Ryan, MD, MBA, FASAM

Elizabeth Salisbury-Afshar, MD, MPH, FAAFP, FACPM, DFASAM

Jasleen Salwan, MD, MPH

Jessie Schaumburg, MD

Lea Selitsky, MD

Jeffrey Selzer, MD, DFASAM

Nishant Shah, MD

Robert C. Sherrick, MD, FASAM

Mishka Terplan, MD, MPH, FACOG, DFASAM

Kinna Thakarar, MD, DO, MPH, FASAM

Paul Trowbridge, MD

Corey Waller, MD, MS, DFASAM, FACEP

Sarah Wakeman, MD, FASAM

Tricia Wright, MD, MS, FACOG, DFASAM

Content Reviewers

Kelly Clark, MD, MBA, DFAPA, DFASAM Vice Chair

Paul Earley, MD, DFASAM ASAM President


Margaret Jarvis, MD, DFASAM

Yngvild Olsen, MD, MPH, DFASAM Chair

ASAM Staff

Maureen Boyle, PhD

Kelly Corredor, JD

Anna Garbar

Nailah Harrell

Leigh Hause-Alvarado, MBA, LMHC

Zach Semple

Request a Taskforce Expert

If you are looking for subject matter experts for your virtual sessions or webinars? ASAM can help you and your organization get in contact with members of our COVID-19 task force.

In order to begin the process of connecting your team with an expert, please send an inquiry to and respond to the following questions:

Which topic area are you seeking expert assistance?
  • Care in Opioid Treatment Programs
  • Office-Based Buprenorphine Treatment
  • Addiction Treatment in Criminal justice Settings or During Re-entry
  • Drug Testing Protocols
  • Addiction Treatment in Hospitals
  • Infection Mitigation in Outpatient Settings
  • Infection Mitigation in Residential Treatment Facilities
  • Treating Addiction in Homeless Populations
  • Considerations for Medication Selection, Dosage or Formulation
  • National & State Regulatory Changes
  • Pregnancy & OUD
  • Telehealth for Addiction Treatment
  • Support Group Participation

Additional questions that will help us find the right expert
  • Are you in need of a specific area of expertise?
  • Which city/state are you located in?
  • Does the expert need to have knowledge of your state?
  • What are your proposed dates?
  • Are you providing an honorarium?